Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases

Stroke

Volumn 34, Issue 9, 2003, Pages 2126-2131

  Strandberg, Timo E ^a   Pitkala, Kaisu H ^b   Linnavuori, Kimmo H ^b   Tilvis, Reijo S ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Bacteremia; Dementia; Herpes simplex; Neuropsychological tests; Viral proteins

Indexed keywords

VIRUS PROTEIN;

AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; COGNITION; COGNITIVE DEFECT; CYTOMEGALOVIRUS; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MYCOPLASMA PNEUMONIAE; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; SENESCENCE; VIRUS LOAD;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HERPESVIRIDAE INFECTIONS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REGISTRIES; SEROEPIDEMIOLOGIC STUDIES; VIRUS DISEASES;

EID: 0042919504     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000086754.32238.DA     Document Type: Article

References (31)

1. Ritchie K, Lovestone S. The dementias. Lancet. 2002;360:1759-1766.
2. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 1993;7:75-83.
3. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057-1060.
4. Weiner HL, Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature. 2002;420:879-884.
5. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 2002;59:880-886.
6. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type I in normal and Alzheimer's disease brains. J Med Virol. 1991;33:224-227.
7. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997;349:241-244.
8. Lin WR, Graham J, MacGowan SM, Wilcock GK, Itzhaki RF. Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimers Rep. 1998;1:173-178.
9. Dobson CB, Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging. 1999;20:457-465.
10. Pyles RB. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors. Herpes. 2001;8:64-68.
11. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF. Herpes-viruses in brain and Alzheimer's disease. J Pathol. 2002;197:395-402.
12. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis. 2002b;9:82-87.
13. Corder EH, Robertson K, Lannfelt L, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998;4:1182-1184.
14. Goplen AK, Liestol K, Dunlop O, Bruun JN, Maehlen J. Dementia in AIDS patients in Oslo: the role of HIV encephalitis and CMV encephalitis. Scand J Infect Dis. 2001;33:755-758.
15. Verreault R, Laurin D, Lindsay J, de Serres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ. 2001;165:1495-1498.
16. Renvoize EB, Awad IO, Hambling MH. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing. 1987;16:311-314.
17. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis. 2002;2:11-17.
18. Gurfinkel E. Link between intracellular pathogens and cardiovascular diseases. Clin Microbiol Infect. 1998;4(suppl 4):S33-S36.
19. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169-175.
20. de la Torre JC. Alzheimer disease as a vascular disorder. Stroke. 2002;33:1152-1162.
21. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol. 1998;187:23-42.
22. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer disease patients. J Clin Microbiol. 2000;38:881-882.
23. Strandberg TE, Pitkälä K, Bergling S, Nieminen MS, Tilvis RS. Multifactorial cardiovascular disease prevention in patients aged 75 years and older: a randomized controlled trial. Am Heart J. 2001;142:945-951.
24. Heyman A, Fillenbaum G, Nash F, eds. Consortium to Establish a Registry for Alzheimer's Disease: the CERAD experience. Neurology. 1997;49(suppl 3):1-19.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
26. Tombaug TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
27. St John PD, Montgomery PR, Kristjansson B, McDowell I. Cognitive scores, even within the normal range, predict death and institutionalization. Age Ageing. 2002;31:373-378.
28. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386-2391.
29. Hokkanen L, Launes J. Cognitive outcome in acute sporadic encephalitis. Neuropsychol Rev. 2000;10:151-167.
30. Lin WR, Jennings R, Smith TL, Wozniak MA, Itzhaki RF. Vaccination prevents latent HSV1 infection of mouse brain. Neurobiol Aging. 2001;22:699-703.
31. Wojtowicz WM, Farzan M, Joyal JL, et al. Stimulation of enveloped virus infection by beta-amyloid fibrils. J Biol Chem. 2002;277:35019-35024.